Recent Posts

History of Alzheimer's

History of Alzheimer's

Today, Alzheimer’s is a leading cause of death and over 560,000 Canadians are living with dementia as of 2016. This number is expected to rise to over 930,000 by 2031. These cases are weighing heavily on Canada’s health care system, and it will only increase as time goes on unless treatments are developed. Below is a brief history of the disease:

(Click to Enlarge)



PMN: ProMIS Neurosciences is a development stage biotech company that discovers and develops game changing precision therapeutics for treatment of neurodegenerative diseases, specifically Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS).





Join Our Investor Group


Enjoyed this story?

Learn more about investing – take a quick tour of 8020 Connect.

Show me the quick tour  tag_faces


Ride The Bull – AKA Investing
  In “Bull Horn”
Invest smartly in the shiny things you enjoy
  In “Bull Horn”

Laura Garet

Laura is 8020 Connect’s Client Communications & Social Media Specialist. In 2014, She received her Bachelor of Communications in Information Design from Mount Royal University in Calgary, Alberta. After a couple brief positions in other marketing roles, Laura has found her home with 8020.

You must be logged in to post a comment.